Permission from Dr. Morisky is required to use the copyrighted Morisky Scales (MMAS-4 and MMAS-8), the most commonly used validated measure of medication non-adherence.
The MMAS Scales are not subject to fair use, as we have had the unfortunate circumstance to litigate against large pharma and prestigious universities in order to protect our intellectual property. Although the settlements are private, public records will show whom we've had to force to comply.
Optimize Medication Adherence
external links with excellent resources to enhance medication adherence efforts:
American Society on Aging/American Society of Consultant Pharmacists Foundation Adult Meducation Set
New York City Medication Adherence Project
In 2015, Medicare began offering monthly reimbursements for chronic care management (CCM). Use of the Morisky Scale for CCM services are billed under CPT 99490 for chronically ill Medicare patients and include at least 20 minutes of non-face to face time directed by a physician or other qualified health care professional, per calendar month. Consent must be documented in the patients medical record.
A HUGE ADVANTAGE for using the Morisky Scales is they are validated with an Internal Consistency Cronbach's alpha .83, Sensitivity 93%, and Specificity 57%.
Congratulations Dr. Morisky for being recognized by the Marquis Who’s Who Top Professionals as having achieved a high level of recognition and achievement in the public health profession.
Philip Morisky, CEO of MMAR, provides an overview of using the MMAS-4 as a screening tool to assess medication non-adherence as part of standard care for a group of pharmacists and students at AUHS.
The MMAS-4 is a highly validated scale that can quickly assess a patient’s medication taking behavior. For patients found to be non-adherent the MMAS-8 scale is not only used for measuring the magnitude of non-adherence but also provides a diagnostic assessment as to why the patient is non-adherent so health care providers can tailor educational counseling sessions and motivational interviewing questions to improve their medication taking behavior.
Thank you, the First Morisky Scale has been cited over 7000 times in medical journals.
Today the MGL scale I published in Medical Care in 1986 has been cited over 7000 times in medical journals. In a large-scale randomized clinical trial, I compared patients who received an educational intervention and educational consultation to patients in a standard care group. 5-year study outcomes identified significant positive differences in patient knowledge of the medical regimen, higher levels of adherence behavior, and reduced levels of morbidity and mortality.
Donald E. Morisky's research while affiliated with County of Los Angeles Public Health and other places
Follow us on Instagram
Donald Morisky receives Distinguished Career Award from American Public Health Association
UCLA Fielding School of Public Health | July 31, 2014
Professor Donald Morisky in the Department of Community Health Sciences at the UCLA Fielding School of Public Health, received the Distinguished Career Award from the Public Health Education and Health Promotion section of the American Public Health Association. The award is given for outstanding contribution to the practice and profession of health education, health promotion and/or health communications.
Morisky directs the School of Public Health's doctoral training program in the social and behavioral determinants of HIV/AIDS, and served as vice-chair of his department from 1994-2003 and chair from 2004-2005. He teaches core courses in program planning, survey research methods and evaluation. He also teaches courses on research methodology and courses on the social and behavioral determinants of HIV/AIDS prevention from a global perspective.
Morisky's research is directed to both chronic and infectious diseases, specifically the risk factors for cardiovascular disease (high blood pressure, diabetes, smoking and elevated cholesterol), tuberculosis control and HIV/AIDS prevention. He has conducted research in the Philippines for over 30 years, and he is currently a co-investigator on an NIA research grant addressing medication-taking behavior among the elderly, in collaboration with the Oschner Clinic at Tulane University.
When using eDOT the major concern for the clinical trial is the lost opportunity of building rapport with the patient to determine if they are “intentionally” or “unintentionally” non-adherent. Some patients thrive on personal contact and the opportunity for tailored counseling.
Intentional medication non-adherence is an active decision from the patient to take their medication as prescribed. This is a process in which a patient makes a rational decision based on the benefits of medication adherence compared to risks of medication non-adherence.
Unintentional medication non-adherence is a passive process in which the patient does not adhere to how the medication is prescribed because they forget, don’t understand, or because of poor health literacy.
Dr Donald Morisky.